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Abstract
Background Inappropriate ionising medical imaging has
been escalating in the last decades. This trend leads to
potential damage to health and has been associated to bio-
ethical and legal issues of patient autonomy.
Methods While the doctrine underlines the importance of
using informed consent to improve patient autonomy and
physician-patient communication, some researchers have ar-
gued that it often falls short of this aim. There are basically
two different informed consent practices. The first — the so-
called “event-based model” — regards informed consent as a
passive signature of a standard unreadable template, performed
only once in each medical pathway. The second — the so-
called “process-basedmodel”— integrates information into the
continuing dialogue between physician and patient, vital for
diagnosis and treatment.
Results Current medical behaviour often embraces the
event-based model, which is considered ineffective and con-
tributes to inappropriateness. We sought, in this review, to
analyse from juridical and communication standpoints
whether process-based informed consent can deal with sci-
entific uncertainties in radiological decision-making. The
informed consent is still a distinctive process in defence of
both patients’ and physicians’ health and dignity in rule-of-
law states and consequently in curtailing the abuse of
ionising medical radiation.
Main Messages
• Inappropriate ionising medical imaging is widespread
and increasing worldwide.
• This trend leads to noteworthy damage to health and is
linked to the issue of patient autonomy.
• Some authors have argued that informed consent often
falls short of improving patient autonomy.
• Process-based informed consent can deal with scientific
uncertainties to contrast inappropriateness.
• Informed consent is still a distinctive process in defence of
both patients and physicians.
Keywords Ionising radiation . Informed consent . Patient
autonomy . Patient autonomy . Risk communication
Introduction
Inappropriateness of medical imaging has been a trending
topic in the last few years [1–4]. The linear growth in the
health care expenditures due to costs of imaging exams [5–7]
along with new evidence that medical radiation may cause
long-term cancer [8, 9] is contributing to the increased inter-
est of the medical community and general population. Stud-
ies demonstrate that imaging exams are responsible for a
45 % increase in health expenditures [5]. In addition, it is
estimated that up to one-third of all imaging exams are
partially or totally inappropriate [3, 10]. As inappropriate-
ness of imaging exams is seen as a potential cause of pa-
tients’ harm, the current ethical and legal forms and rules are
being reviewed, as well as the informed consent process,
which is one of the most important tools to protect patients
and physicians.
Clinical imaging has conferred undoubted benefits on
modern medical practice. But this does not mitigate the fact
that even with low ionising exposure every radiological or
nuclear medicine examination may lead to a long-term risk
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of cancer in patients [8, 9]. In the context of informed consent,
individuals subjected to ionising radiation often receive inad-
equate or no information about the radiation exposure dose
and the potential risk related to the dose received.
The main aim of this article is to discuss the role and impact
of the informed consent process in patients undergoing imaging
exams containing ionising radiation. The legal aspects of the
informed consent process, risk communication and uncertainties
within the consent process are also emphasised in this review.
The trade-off: risks and benefits of ionising imaging
Physicians must justify their decision to request an imaging
exam using ionising radiation, and the decision is based on a
trade-off between risks and benefits [11]. The benefits from
diagnostic procedures utilising radiation must overcome the
risks [12, 13]. The decision must consider the likelihood of
immediate benefit as well as future damage to health [14–17].
In order to make a decision, clinicians must be familiar with
the given radiation dose and the possible harmful effects of the
radiation exposure [12]. Without solid knowledge of the radi-
ation risk from imaging exams, physicians are unable to
properly ponder the risks compared to potential benefits and
may find it difficult to justify the exposure of patients to
medical radiation [18–21]. Referral guidelines can partially
replace the lack of deep knowledge [22–25]. Limited knowl-
edge about radiation and an inadequate use of guidelines
indicate a suboptimal justification of referrals [25].
Many studies reveal important shortcomings in physi-
cians’, as well as in medical students’, awareness and knowl-
edge about radiation risk [18–21]. Since today’s medical
students are future medical practitioners, they will be unable
to make appropriate informed clinical decisions unless they
are taught principles of radiation protection. Awhite paper of
the European Society of Radiology [26]—in line with the
European MED Directive [27]—emphasises that undergrad-
uate and graduate students need to acquire a broader and
deeper understanding of the hazards of radiation, patients’
protection, awareness of which tests deliver a larger absorbed
radiation dose, the value of alternative investigations without
the use of radiation, etc. In addition, undergraduate and grad-
uate students need to comprehend the principle of informed




The doctrine underlines the ideal of using informed consent to
improve patient autonomy and physician-patient communication.
Nevertheless, some authors argue that informed consent itself
often fails to achieve this goal [29–32]. Other authors describe the
difference between the doctrine and the operational ap-
plication of informed consent, which is still imperfect
and requires improvement [33–36].
Following a representative then simplified perspective,
there are basically two manners in which to implement the
informed consent (see Table 1), and they are described by
two models: the event- and the process-based model. The
event-based model, the one most often used [37–40], can be
applied at a given moment and in any diagnostic path. This
procedure must, therefore, cover all the legal elements in that
precise circumstance in which the template will be subjected
to being signed by the patient [36, 41]. The event-based
model impedes the patient from deciding freely and deliber-
ately, as the patient remains unaware of possible biological
consequences of radiological interventions. Also, physicians
are not fully protected under the event-based model, as—by
using this ineffective communication approach—they can
carry out unsuccessful clinical acts more frequently, with
legal consequences. Research has shown that effective
patient-physician communication can improve health out-
comes [42–45]. On the other hand, a lack of physician-
patient communication also generates more recurrent medi-
cal litigations [46–49]. The event-based model is considered
ineffective [37, 41, 50, 51], additionally contributing to
inappropriateness, as only written information is provided
and this does not necessarily imply that patients are truly
informed about the risks and benefits of the examination and
potential alternatives [52, 53].
The process-based model, on the contrary, integrates the
information process to the patients in an outgoing dialogue
with the physicians as part of the diagnostic and treatment
routine [36, 41]. Authors suggest that the process-based
model shows many advantages compared to the event-
based model, such as enhancing the physician-patient inter-
action, thus the responsibility from both parts [36, 41].
General approach
The arbitrary nature of the medical act is well known in
Italian criminal law, which prosecutes illegal medical acts
such as the lack of informed consent, providing inadequate
or incomplete information, and communicative disclosure
between the physician and patient.
After being fully informed by their physicians, patients
should carefully read the consent form before agreeing with
the medical act [54–57]. If patients are unaware of the
radiation risk from imaging exams, they will therefore not
perceive the intrinsic danger; consequently, a signature on
the consent form will not be legally valid.
Physicians have an ethical and legal responsibility when
requesting a patient to sign a consent form agreeing to a risky
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medical act [58–60]. The possibility of a patient developing
cancer as a result of ionising radiation is often omitted by the
physician requesting or performing the imaging exam. This
is the result of several malfunctions such as poor interaction
and/or communication between the physician and patient,
lack of clinical appropriateness and lack of organisational
appropriateness. The latter is a cause of internal disecon-
omies within clinical structures, where ionising imaging
represents a large segment of clinical practice. Specifically,
these diseconomies include (1) an increased incidence of
civil litigation; (2) increased insurance premiums for medical
responsibility; (3) a consequent refusal by insurance compa-
nies to assume the warranty of the clinical risks; (4) longer
waiting lists; (5) more general and unsustainable waste in
healthcare expenditures.
The physicians must justify their own prescriptions, from
a clinical and legal standpoint, as well as the carrying out the
procedure. The Euratom Law states that an examination
involving radiation exposure must be justified in advance
before a patient is referred to a radiologist or nuclear medi-
cine physician [27]. The justification integrates scientific and
clinical elements with a certain type of ionising technology
to be used. Therefore, it is precisely in this correlation
between the use of ionisation and the specific patient’s dis-
ease that the legal right to “real” informed consent is ac-
knowledged [58–60]. According to some authors, it is rea-
sonable that the provision of risk information within the
informed consent process should be mandatory only for
procedures with a radiation dose higher than 1 mSv, such
as CT, nuclear medicine exams, positron emission tomogra-
phy (PET), PET/CT and fluoroscopic procedures [58, 61, 62].
An important problem linked to informed consent is the
time factor, whether informed consent expressed immediate-
ly before the execution of the radiological procedure is
legally valid [59, 60]. In response to this question concerning
the timing of informed consent, we should remember that
information, dialogue and trust between the physician and
patient should exist within a planned and active clinical
implementation [61]. Thus, it is imperative an appropriate
chronological separation between conveying the information
to the patient and the implementation of the procedure
utilising radiation [60]. Only in this way, can the communi-
cative and legal intent be preserved in order to minimise any
psychological coercion connected to the time factor influencing
the willingness of the patient to provide informed consent. The
decision-making autonomy of the patient—a fortiori and in this
specific type of informed consent—cannot be constrained by
the time factor, which even more strongly collides with the
specific scientific and clinical significance of the radiological
risk, as well as with complex problems related to effective
communication [58–60].
Results from a study showed that communication, time to
talk and information are probably the most important features
that patients desire from their physicians, including from radi-
ologists [63]. A study [64] demonstrated, that even in a busy
practice driven by time constraints and financial pressure, 80 %
of the patients were satisfied and were able to convey their
problems to physicians in only 2 min of interaction [64].
Table 1 Two models of informed consent implementation [36, 41]
Dimensions Event-based model Process-based model
Time span The decision must be regarded as an act placed in a limited and
short time span, in which the physician provides the patient with
all the information about the diagnosis procedure that he/she
intends to adopt. The patient will have to accept it or reject it
The decision is determined and defined continuously throughout
the time span of the diagnostic process and therefore of the
doctor-patient relationship. The consensus is built on the
perspective of an active participation by the patient with the
medical decision-making
Procedure Informed consent is an additional procedure within the unchanged
decision-making process
Informed consent is integrated into the doctor-patient relationship
as a transverse component to all the aspects of information/
communication and the clinical decision-making processes
Involved
actors
The consent can be gathered from any health operator belonging to
the involved staff




The consent form is considered as the backbone of the event
model. The importance of providing complete and accurate
information that meets most of the legal requirements of the
informed consent process is emphasised
The focus of the “process”model is not so much the module itself,
but rather a series of information and communicative acts
that—together with the module itself—are performed within the
diagnostic process
Interaction A more bureaucratic interaction is produced, with two
consequences: the perception by physicians of a sense of
futility; the perception by patients that their real participation in
decision-making is neither sought nor important
The model requires that the doctor and patient enter into an
ongoing dialogue, which is defined as “mutual monitoring”
Perspective The consent is given as part of the medical act limited to the
diagnosis date
Informed consent is an integral part of the therapeutic alliance, as a
vision that is generated in the doctor-patient relationship and
extends in a broad sense to the structure, the territory and the
National Health System
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Therefore, physicians should not blame their busy schedule to
justify poor interaction with their patients or a lack of time to
properly explain the risks and benefits of complementary
exams to their patients.
Risk communication
Risk communication is a projection of the legal duty of the
physician. This projection should be related to the patients’
rights to have input concerning medical acts that could
damage their health or expose them to a real middle- or
long-term danger of death. Failure to provide such informa-
tion to the patient in the context of informed consent can
subsequently (and in court) lead to the investigation and
possible conviction of the professional who performed an
arbitrary act of ionising imaging. This occurs when the
physician—prior to the exam—does not explain the risks
and benefits connected to the diagnostic act to the patient,
and the patient cannot exercise an explicit, free and con-
scious choice (acceptance or rejection).
Another aspect of informed consent in ionising medical
imaging regards the concept of population statistics and risks
[29]. Many studies about risk communication have addressed
the difficulty of conveying correct information to patients, and
they have suggested interesting solutions [65–68], such as the
use of visual displays [66, 68]. Visual displays include risk
ladders, human and Chernoff faces, line graphs, dots and Xs in
which the Xs represent those affected by the hazard, marbles,
pie charts and histograms. Evidence mostly suggests that
combining visuals with numerical and written descriptions
improves the perceived helpfulness of the information and
the accuracy of perceived risk [68]. Another solution is pro-
vided by consistent and robust literature showing that people
better understand risk information (in terms of gross compar-
ison and risk assessment tasks) if risks are presented in terms
of frequencies (e.g., 5 out of 100 people) rather than in
percentages (5 %) [66, 69].
Scientific uncertainty as an obstacle in informed consent
The role of the physician is arguable in certain situations,
such as when the physicians have to share scientifically
controversial data with their patients, even if the data are
significant, such as the potential cancer risk of low levels of
medical radiation [29]. These uncertainties are expressed in
terms of scientific reliability from a clinical and legal stand-
point, generating many consequences. We refer in particular
to managing these uncertainties in the context of risk com-
munication, as an atypical legal duty inherent in informed
consent in radiology and nuclear medicine. Uncertainties in
risk can jeopardise the fundamental right to patients’ health
and should not be omitted by the physicians. Uncertainties
can be determined and clarified via risk communication
solutions and by providing a justification and consideration
of risks and benefits, essential elements in obtaining in-
formed consent for any medical act that may have potential
risk [70].
Some authors argue that informed consent cannot account
for stochastic risk uncertainties [29]. In this scenario, patients
must be fully informed of what is known and what is un-
known, but it is not advisable to establish a contract between
a patient and the physician that reflects uncertainty [29]. On
the contrary, we claim that patients must be fully informed
about the potential risks in order to provide their consent,
even if the potential risks are based on controversial scien-
tific data.
The main dispute relating to discussing radiation risk with
patients focusses on the certitude of radiation risk estimates
[61] and the linear no-threshold risk model for assessing
potential correlation between radiation and cancer. It is nec-
essary to take into account several important factors, as
proposed in the following points.
(1) The linear no-threshold risk model is endorsed by all
the major radiation regulatory boards, including the
International Commission on Radiological Protection
[11, 12], the National Academy of Sciences BEIR com-
mittee [71], the United Nations Scientific Committee
on the Effects of Atomic Radiation [72] and the US
Food and Drug Administration [73]. The BEIR VII
summary claims that, at lower doses without a thresh-
old, the cancer risk progresses in a linear fashion and
that even the smallest dose can potentially provoke a
slight increase in cancer risk to humans [71]. Low dose
is defined by the BEIRVII committee as doses ranging
from zero to 100 mSv.
(2) Most published articles that examine medical radiation
in a scientific fashion suggest a significant risk
[9, 74–76].
The tendency to justify a mild misperception of low risk
has no scientific basis and is misleading from a legal stand-
point. This is significant for radiologists or any physician
who requests an imaging exam. We cannot ignore the scien-
tifically proven fact that the different types of ionising radi-
ation, artificial or natural, produce a cumulative effect of
low-level chronic exposure and are related to adverse effects
on human cells [4, 13, 22, 23].
Efforts can be made to assess the relative importance of
the several epidemiological uncertainties. There are some
approaches to quantifying uncertainties in lifetime attribut-
able risk, like for instance that followed by the Monte Carlo
method [77]. Nevertheless, the linear no-threshold model is
still considered as the most robust model for medical
decision-making about radiation exposure and cancer risk.
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This model should be used in conjunction with general dose
optimisation strategies [27] and increased use of protocols
[27] and patient-individualised information [77].
The attention to scientific uncertainty opens a reflection of
alternative and non-ionising diagnostic procedures, justified
by similarities of diagnostic information and management of
clinical cases. Accordingly, the Euratom Law establishes that
a non-ionising technique must be used whenever it will
provide information grossly comparable to that provided by
an ionising radiation technique [27].
From this viewpoint, the problem focussed on should not
be “whether” informed consent should be performed or not,
but rather “how” this universal legal institution should deal
with the ever-present scientific uncertainties [70]. The real
problem is how to communicate risk in a way that is under-
standable to the patient. Informed consent should include
risk uncertainties [70]. If this were not so, not only all
informed consent forms (even those for issues other than
ionising imaging), but also all drug leaflets (in which there
is a contract subtended between a consumer and a pharma-
ceutical company) would be eliminated. In fact, all the risks
that are normally described within informed consent deal
with uncertainties and intrinsically have a stochastic nature.
Conclusion
Information and clinical argumentation within the frame-
work of informed consent in radiology and nuclear medicine
have significant legal importance. One aspect is the degree of
validity of scientific sources on which effective risk commu-
nication about ionising radiation should be based. There
should be particular focus on evidence-based medicine,
which should be state of the art in every branch of medical
research. Thus, the legal principles of diligence, prudence
and expertise, which every physician must follow when
carrying out a medical act, should be extended to the pre-
ventive obligation of clinical information and communica-
tion in the context of informed consent.
The legal validity of informed consent for ionising imag-
ing cannot allow omission of information dictated by scien-
tific and clinical uncertainties. On the contrary, if well-
communicated by the physician, uncertainty can pro-
actively contribute to the formation of a conscious decision
by the patient.
In the eyes of the law, two key aspects must be considered.
(1) The evaluation of the continuous training of radiologists
and nuclearmedicine physicians in relation to the technical-
scientific sources to be used in the context of the overall
informed consent process. These sources should be
characterised by scientific rigor and the presence of scien-
tific data—with consequent clinical information—that are
worthy of note. Currently, this can be provided accurately
by means of evidence-based medicine.
(2) The continuous training of radiologists and nuclear
medicine physicians in the techniques and tools of
physician-patient communication and risk communica-
tion. Physician must be able to discuss technical knowl-
edge with the patient and to deal with patient’s feeling
of “fear” whenever patients are subjected to risky clin-
ical activities such as ionising imaging. Information and
communication by the physician should be calibrated
according to the specific pathological condition of the
patient. This justifies both the correctness of the act of
ionising imaging and the validity of the resulting con-
sensus expressed by the patient.
This perspective, founded on a process-based vision of
informed consent and shared decision-making, deserves to
be extended under both a clinical and legal profile, even to
informed consent characterised by a “contract” matrix, typ-
ically conceived and applied within the framework of the
Anglo-Saxon legal tradition.
On this basis, the subject of informed consent in ionising
medical imaging, although addressed differently in legal
profiles in the different worlds of Common Law and Civil
Law, appears analogous if we focus on the information and
communication process regarding radiation risk when
implementing informed consent. It is a unique methodolog-
ical approach, applicable with respect to both the law as
applied in theWestern world and going beyond state borders.
This reinforces the idea that the concrete implementation of
the informed consent process in ionising medical imaging is
the only way to:
& Protect the universal patient right to decide on their
psycho-physical well-being in the context of “risky” acts
of nuclear and radiological medicine.
& Allow physicians to develop greater communication
skills and be legally protected, within a framework cur-
rently characterised by major doubts, issues and aspects
of inappropriateness, both operational and relational.
Certainty regarding this topic must be ascribed to ethical
and legal condemnation, in both Common Law and Civil
Law jurisdictions, of all those attitudes and behaviours of
defensive medicine or characterised by the lack of appropri-
ate communication, at the levels of both the structures and
the individual doctor-patient relationship.
Following our analysis of the main problems linked to the
controversy about scientific uncertainties, we concur with a
series of authors that informed consent is still a distinctive
process that defends patient health as well as both patient and
physician dignity and autonomy in rule-of-law states [18, 61,
70, 78, 79]. By means of an overall strategy and model of
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communication, shared decision-making and balanced legal
protection, one will be able to implement the best possible
informed consent, founded on a “process-based” vision. This
can contribute significantly to patient autonomy, radiation pro-
tection and appropriateness in ionising medical imaging.
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